TNK BIOTECH ApS: Financial statements 2015
CVR: 30691911
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
TNK BIOTECH ApS (CVR 30691911) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -32,465 and a net result of DKK -40,518 compared with DKK -10,712 the year before. Equity in the 2015 report amounted to DKK 47,838. The solvency ratio was 43.6%.
- Gross Profit
- DKK -32,465
- Profit/Loss
- DKK -40,518
- Equity
- DKK 47,838
- Total Assets
- DKK 109,731
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -32 t. | -41 t. | 48 t. | - |
| 2014 | - | -8 t. | -11 t. | 88 t. | - |
| 2013 | - | 269 t. | 75 t. | 99 t. | - |
| 2012 | - | - | - | - | - |
Official annual report
How creditworthy is TNK BIOTECH ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
TNK BIOTECH ApS has published its annual report for 2014. Gross profit came to DKK -8,378, and the net result was DKK -10,712.
About TNK BIOTECH ApS
TNK BIOTECH ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2007. The company is registered under the industry Investering for egen regning. The company was previously named TNK INVEST ApS. The management consists of Thomas Nitschke Kledal. The company is owned by Thomas Nitschke Kledal. The company has 0 employees (2013). In 2025, the company reported a gross profit of DKK -11,363 and a net result of DKK -17,528 compared with DKK -15,724 the year before. Equity in the 2025 report amounted to DKK -82,154.